BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 27260001)

  • 1. Regulation of HK2 expression through alterations in CpG methylation of the HK2 promoter during progression of hepatocellular carcinoma.
    Lee HG; Kim H; Son T; Jeong Y; Kim SU; Dong SM; Park YN; Lee JD; Lee JM; Park JH
    Oncotarget; 2016 Jul; 7(27):41798-41810. PubMed ID: 27260001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenomic profiling of DNA methylation for hepatocellular carcinoma diagnosis and prognosis prediction.
    Zhang C; Ge S; Wang J; Jing X; Li H; Mei S; Zhang J; Liang K; Xu H; Zhang X; Zhang C
    J Gastroenterol Hepatol; 2019 Oct; 34(10):1869-1877. PubMed ID: 31038805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypoxia induces genomic DNA demethylation through the activation of HIF-1α and transcriptional upregulation of MAT2A in hepatoma cells.
    Liu Q; Liu L; Zhao Y; Zhang J; Wang D; Chen J; He Y; Wu J; Zhang Z; Liu Z
    Mol Cancer Ther; 2011 Jun; 10(6):1113-23. PubMed ID: 21460102
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methylome analysis and integrative profiling of human HCCs identify novel protumorigenic factors.
    Neumann O; Kesselmeier M; Geffers R; Pellegrino R; Radlwimmer B; Hoffmann K; Ehemann V; Schemmer P; Schirmacher P; Lorenzo Bermejo J; Longerich T
    Hepatology; 2012 Nov; 56(5):1817-27. PubMed ID: 22689435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methylation of Tip30 promoter is associated with poor prognosis in human hepatocellular carcinoma.
    Lu B; Ma Y; Wu G; Tong X; Guo H; Liang A; Cong W; Liu C; Wang H; Wu M; Zhao J; Guo Y
    Clin Cancer Res; 2008 Nov; 14(22):7405-12. PubMed ID: 19010857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CpG island methylator phenotype association with elevated serum alpha-fetoprotein level in hepatocellular carcinoma.
    Zhang C; Li Z; Cheng Y; Jia F; Li R; Wu M; Li K; Wei L
    Clin Cancer Res; 2007 Feb; 13(3):944-52. PubMed ID: 17289889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CpG island methylator phenotype association with upregulated telomerase activity in hepatocellular carcinoma.
    Zhang C; Guo X; Jiang G; Zhang L; Yang Y; Shen F; Wu M; Wei L
    Int J Cancer; 2008 Sep; 123(5):998-1004. PubMed ID: 18546260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The Evaluation Value of Methylation Status of CpG Island of SFRP1 and LINE1 Gene Promoter Area in the Prognosis of Hepatocellular Carcinoma.].
    Huang Y; Wei L; Sun AM; Zhao RC; Zhang J; Yang HT; Li B; Sun CJ; Ding XQ; Gao B; Zhong YQ; Qin Y
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2016 Nov; 47(6):883-888. PubMed ID: 28598118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CpG island methylator phenotype associated with tumor recurrence in tumor-node-metastasis stage I hepatocellular carcinoma.
    Li B; Liu W; Wang L; Li M; Wang J; Huang L; Huang P; Yuan Y
    Ann Surg Oncol; 2010 Jul; 17(7):1917-26. PubMed ID: 20112070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrative analysis of aberrant Wnt signaling in hepatitis B virus-related hepatocellular carcinoma.
    Ding SL; Yang ZW; Wang J; Zhang XL; Chen XM; Lu FM
    World J Gastroenterol; 2015 May; 21(20):6317-28. PubMed ID: 26034368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Promoter hypermethylation of DNA damage response genes in hepatocellular carcinoma.
    Li Z; Zhang H; Yang J; Hao T; Li S
    Cell Biol Int; 2012 May; 36(5):427-32. PubMed ID: 21864295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation of CpG island methylator phenotype with poor prognosis in hepatocellular carcinoma.
    Cheng Y; Zhang C; Zhao J; Wang C; Xu Y; Han Z; Jiang G; Guo X; Li R; Bu X; Wu M; Wei L
    Exp Mol Pathol; 2010 Feb; 88(1):112-7. PubMed ID: 19879258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Correlations of CpG island methylator phenotype and OPCML gene methylation to carcinogenesis of hepatocellular carcinoma].
    Liu WJ; Wang L; Wang JP; Li JQ; Zhang CQ; Zheng L; Yuan YF
    Ai Zheng; 2006 Jun; 25(6):696-700. PubMed ID: 16764763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SOCS3 Methylation Predicts a Poor Prognosis in HBV Infection-Related Hepatocellular Carcinoma.
    Zhang X; You Q; Zhang X; Chen X
    Int J Mol Sci; 2015 Sep; 16(9):22662-75. PubMed ID: 26393582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aberrant CpG island hypermethylation and down-regulation of Oct-6 mRNA expression in human hepatocellular carcinoma.
    Sun JZ; Yang XX; Li XH; Xu WW; Wang Y; Zhu W; Li M
    Dig Dis Sci; 2011 Oct; 56(10):3072-7. PubMed ID: 21448695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CSN5 upregulates glycolysis to promote hepatocellular carcinoma metastasis via stabilizing the HK2 protein.
    Huang M; Xiong H; Luo D; Xu B; Liu H
    Exp Cell Res; 2020 Mar; 388(2):111876. PubMed ID: 31991125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Using Illumina Infinium HumanMethylation 450K BeadChip to explore genome‑wide DNA methylation profiles in a human hepatocellular carcinoma cell line.
    Sun N; Zhang J; Zhang C; Shi Y; Zhao B; Jiao A; Chen B
    Mol Med Rep; 2018 Nov; 18(5):4446-4456. PubMed ID: 30221710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Correlation between epigenetic alterations in the insulin growth factor-II gene and hepatocellular carcinoma].
    Dong ZZ; Yao DF; Wu W; Qiu LW; Yao NH; Yan XD; Yu DD; Chen J
    Zhonghua Gan Zang Bing Za Zhi; 2012 Aug; 20(8):593-7. PubMed ID: 23207153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypomethylation of long interspersed nuclear element-1 (LINE-1) is associated with poor prognosis via activation of c-MET in hepatocellular carcinoma.
    Zhu C; Utsunomiya T; Ikemoto T; Yamada S; Morine Y; Imura S; Arakawa Y; Takasu C; Ishikawa D; Imoto I; Shimada M
    Ann Surg Oncol; 2014 Dec; 21 Suppl 4():S729-35. PubMed ID: 24992910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genome-wide profiling of DNA methylation and tumor progression in human hepatocellular carcinoma.
    Nishida N; Nishimura T; Nakai T; Chishina H; Arizumi T; Takita M; Kitai S; Yada N; Hagiwara S; Inoue T; Minami Y; Ueshima K; Sakurai T; Kudo M
    Dig Dis; 2014; 32(6):658-63. PubMed ID: 25376281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.